NCT01320930已完成不适用
Early Detection and Rehabilitation of Subjects With COPD - Rehabilitation in Moderate COPD
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 61
研究概览
简要总结
The study is a single-center randomized, unblinded, placebo-controlled study to investigate the effect of pulmonary rehabilitation in subjects with moderate chronic obstructive pulmonary disease (COPD).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A diagnosis of moderate COPD.
- •Motivation for Pulmonary rehabilitation.
排除标准
- •Comorbidity contraindicating rehabilitation.
- •Participation in pulmonary rehabilitation within the last year.
- •Cognitive disorders limiting the ability to participate in physical training and education sessions.
研究组 & 干预措施
Pulmonary rehabilitation
Active Comparator
A standardized 7 week rehabilitation program, including physical training and education.
干预措施: Pulmonary rehabilitation (Behavioral)
Control
Placebo Comparator
Conventional care
干预措施: conventional care (Behavioral)
研究者
相似试验
已完成
不适用
Study of the Intervention Effect of Self-help Training Camps in Promoting Mental Health Among Perinatal WomenMental HealthPerinatal DepressionPerinatal DepressionMental HealthPerinatal DepressionNCT06405932Fangbiao Tao1,691
终止
1 期
MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's DiseaseAlzheimer DiseaseMild Cognitive ImpairmentNCT04121208University of Oxford2
已完成
1 期
AZD7325 Single Ascending Dose Study in Healthy Male Japanese SubjectsHealthy VolunteerNCT00769899AstraZeneca48
已完成
1 期
Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy ParticipantsHealthy ParticipantsNCT05107336AstraZeneca44
已完成
1 期
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BVL-GSK098 in Healthy VolunteersHealthy VolunteersNCT04654143BioVersys AG80